XML 50 R39.htm IDEA: XBRL DOCUMENT
v3.23.2

SHARE-BASED COMPENSATION (Tables) | 9 Months Ended
--- | ---
Jul. 30, 2023
SHARE-BASED COMPENSATION [Abstract] |
Share-based Compensation Expenses | The table below presents information on our share-based compensation expenses for the three and nine-month periods ended July 30, 2023, and July 31, 2022.
|  | Three Months Ended |  |  | Nine Months Ended |
|  | July 30, 2023 |  |  | July 31, 2022 |  |  | July 30, 2023 |  |  | July 31, 2022 |
Expense reported in: |  |  |  |  |  |  |  |  |  |  |  |
Cost of goods sold |  | $ | 322 |  |  | $ | 303 |  |  | $ | 892 |  |  | $ | 628 |
Selling, general, and administrative |  |  | 1,499 |  |  |  | 1,115 |  |  |  | 4,407 |  |  |  | 3,539 |
Research and development |  |  | 222 |  |  |  | 163 |  |  |  | 575 |  |  |  | 456 |
Total expense incurred |  | $ | 2,043 |  |  | $ | 1,581 |  |  | $ | 5,874 |  |  | $ | 4,623 |
Expense by award type: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock awards |  | $ | 2,043 |  |  | $ | 1,506 |  |  | $ | 5,782 |  |  | $ | 4,189 |
Stock options |  |  | - |  |  |  | 20 |  |  |  | 1 |  |  |  | 279 |
Employee stock purchase plan |  |  | - |  |  |  | 55 |  |  |  | 91 |  |  |  | 155 |
Total expense incurred |  | $ | 2,043 |  |  | $ | 1,581 |  |  | $ | 5,874 |  |  | $ | 4,623 |
Income tax benefits of share-based compensation |  | $ | 152 |  |  | $ | 135 |  |  | $ | 513 |  |  | $ | 323 |
Share-based compensation cost capitalized |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
Restricted Stock Awards Activity | The table below presents information on our restricted stock awards for the three and nine-month periods ended July 30, 2023, and July 31, 2022.
|  | Three Months Ended |  |  | Nine Months Ended |
|  | July 30, 2023 |  |  | July 31, 2022 |  |  | July 30, 2023 |  |  | July 31, 2022 |
Number of shares granted in period |  |  | - |  |  |  | 107,824 |  |  |  | 786,500 |  |  |  | 643,224 |
Weighted-average grant-date fair value of awards (in dollars per share) |  | $ | - |  |  | $ | 15.95 |  |  | $ | 16.77 |  |  | $ | 18.72 |
Compensation cost not yet recognized |  | $ | 14,511 |  |  | $ | 10,256 |  |  | $ | 14,511 |  |  | $ | 10,256 |
Weighted-average amortization period for cost not yet recognized (in years) |  |  | 2.9 |  |  |  | 2.8 |  |  |  | 2.9 |  |  |  | 2.8 |
Shares outstanding at balance sheet date |  |  | 1,267,247 |  |  |  | 916,554 |  |  |  | 1,267,247 |  |  |  | 916,554 |
Stock Options Activity | The table below presents information on our stock options for the three and nine-month periods ended July 30, 2023, and July 31, 2022.
|  | Three Months Ended |  |  | Nine Months Ended |
|  | July 30, 2023 |  |  | July 31, 2022 |  |  | July 30, 2023 |  |  | July 31, 2022 |
Number of options granted in period |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Cash received from options exercised |  | $ | 512 |  |  | $ | 1,007 |  |  | $ | 1,094 |  |  | $ | 5,157 |
Compensation cost not yet recognized |  | $ | - |  |  | $ | 33 |  |  | $ | - |  |  | $ | 33 |
Weighted-average amortization period for cost not yet recognized (in years) |  |  | - |  |  |  | 0.5 |  |  |  | - |  |  |  | 0.5 |
Information on Outstanding and Exercisable Option | Information on outstanding and exercisable option awards as of July 30, 2023, is presented below.
Options |  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Aggregate Intrinsic Value |
Outstanding and exercisable at July 30, 2023 |  |  | 473,300 |  |  | $ | 10.17 |  |  |  | 2.80 |  |  | $ | 7,600 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (d)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration